Beta Bionics, Inc. BBNX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.54% | 6.38% | -33.68% | -40.27% | -60.33% |
| Total Depreciation and Amortization | 55.06% | 40.19% | 25.93% | 7.44% | 42.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.95% | -27.18% | 73.67% | 29.22% | 21.31% |
| Change in Net Operating Assets | 30.51% | 21.87% | 25.98% | -7.03% | -54.33% |
| Cash from Operations | 2.87% | 2.36% | -5.49% | -40.25% | -87.00% |
| Capital Expenditure | -21.92% | -90.88% | -56.02% | -25.68% | -274.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 135.30% | 123.81% | -120,135.11% | -369.11% | -217.94% |
| Cash from Investing | 131.44% | 120.06% | -4,583.69% | -344.76% | -219.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.09% | -97.93% | 210,560.78% | 292,847.95% | 782,288.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -109.25% | -3,284.87% |
| Cash from Financing | -97.70% | -98.36% | 286.36% | 21,449.05% | 290,183.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.08% | -160.09% | -70.41% | 124.70% | 124.64% |